These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 7692435)

  • 1. Structure-function analysis of human IL-1 alpha: identification of residues required for binding to the human type I IL-1 receptor.
    Labriola-Tompkins E; Chandran C; Varnell TA; Madison VS; Ju G
    Protein Eng; 1993 Jul; 6(5):535-9. PubMed ID: 7692435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Site-directed mutagenesis--molecular biology and rational drug design.
    Ju G; Labriola-Tompkins E; Varnell T; Madison V; Graves B
    Agents Actions Suppl; 1995; 47():155-9. PubMed ID: 7785490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mapping receptor binding sites in interleukin (IL)-1 receptor antagonist and IL-1 beta by site-directed mutagenesis. Identification of a single site in IL-1ra and two sites in IL-1 beta.
    Evans RJ; Bray J; Childs JD; Vigers GP; Brandhuber BJ; Skalicky JJ; Thompson RC; Eisenberg SP
    J Biol Chem; 1995 May; 270(19):11477-83. PubMed ID: 7744786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of the discontinuous binding site in human interleukin 1 beta for the type I interleukin 1 receptor.
    Labriola-Tompkins E; Chandran C; Kaffka KL; Biondi D; Graves BJ; Hatada M; Madison VS; Karas J; Kilian PL; Ju G
    Proc Natl Acad Sci U S A; 1991 Dec; 88(24):11182-6. PubMed ID: 1837145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mapping of neutralizing epitopes and the receptor binding site of human interleukin 1 beta.
    Simon PL; Kumar V; Lillquist JS; Bhatnagar P; Einstein R; Lee J; Porter T; Green D; Sathe G; Young PR
    J Biol Chem; 1993 May; 268(13):9771-9. PubMed ID: 7683661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A mutational analysis of receptor binding sites of interleukin-1 beta: differences in binding of human interleukin-1 beta muteins to human and mouse receptors.
    Grütter MG; van Oostrum J; Priestle JP; Edelmann E; Joss U; Feige U; Vosbeck K; Schmitz A
    Protein Eng; 1994 May; 7(5):663-71. PubMed ID: 8073036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble type II interleukin 1 (IL-1) receptor binds and blocks processing of IL-1 beta precursor and loses affinity for IL-1 receptor antagonist.
    Symons JA; Young PR; Duff GW
    Proc Natl Acad Sci U S A; 1995 Feb; 92(5):1714-8. PubMed ID: 7878046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loop substitution as a tool to identify active sites of interleukin-1 beta.
    Palla E; Bensi G; Solito E; Buonamassa DT; Fassina G; Raugei G; Spano F; Galeotti C; Mora M; Domenighini M
    J Biol Chem; 1993 Jun; 268(18):13486-92. PubMed ID: 7685764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mapping of receptor binding sites on IL-1 beta by reconstruction of IL-1ra-like domains.
    Boraschi D; Bossù P; Ruggiero P; Tagliabue A; Bertini R; Macchia G; Gasbarro C; Pellegrini L; Melillo G; Ulisse E; Visconti U; Bizzarri C; Del Grosso E; Mackay AR; Frascotti G; Frigerio F; Grifantini R; Grandi G
    J Immunol; 1995 Nov; 155(10):4719-25. PubMed ID: 7594472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A single amino acid difference between human and monkey interleukin (IL)-1beta dictates effective binding to soluble type II IL-1 receptor.
    Smith DE; Ketchem RR; Moore H; Anderson Z; Renshaw BR; Friend DJ; Sims JE
    J Biol Chem; 2002 Dec; 277(49):47619-25. PubMed ID: 12356774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The internalized interleukin-1 activation complex in fibroblasts localizes to the Golgi apparatus.
    Praast G; Hofmeister R; Grube K; Hans W; Kühlwein T; Krammer PH; Falk W
    J Inflamm; 1995-1996; 46(3):125-38. PubMed ID: 8844493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Independent binding of interleukin-1 alpha and interleukin-1 beta to type I and type II interleukin-1 receptors.
    Slack J; McMahan CJ; Waugh S; Schooley K; Spriggs MK; Sims JE; Dower SK
    J Biol Chem; 1993 Feb; 268(4):2513-24. PubMed ID: 8428929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential sensitivity to Arg side chain modification of IL-1 beta binding to type I and type II receptors.
    Tömösközi Z; Bugovics G; Koncz S; Arányi P
    Agents Actions; 1994 Mar; 41(1-2):105-7. PubMed ID: 8079812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterogeneity of type-II interleukin-1 receptors. Heterogeneity of B-cell interleukin-1 binding created by dimerization of type-II interleukin-1 receptors.
    Cronkhite RI; Lobick JJ; Plate JM
    Hum Immunol; 1993 Feb; 36(2):128-36. PubMed ID: 8463123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type I IL-1 receptor: ligand specific confirmation differences and the role of glycosylation in ligand binding.
    Einstein R; Jackson JR; D'Alessio K; Lillquist JS; Sathe G; Porter T; Young PR
    Cytokine; 1996 Mar; 8(3):206-13. PubMed ID: 8833035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HepG2 cells predominantly express the type II interleukin 1 receptor (biochemical and molecular characterization of the IL-1 receptor).
    Giri JG; Robb R; Wong WL; Horuk R
    Cytokine; 1992 Jan; 4(1):18-23. PubMed ID: 1319762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding of IL-1 alpha, IL-1 beta, and IL-1 receptor antagonist by soluble IL-1 receptors and levels of soluble IL-1 receptors in synovial fluids.
    Arend WP; Malyak M; Smith MF; Whisenand TD; Slack JL; Sims JE; Giri JG; Dower SK
    J Immunol; 1994 Nov; 153(10):4766-74. PubMed ID: 7963543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An antibody to a 17 amino acid synthetic peptide of the type I interleukin-1 receptor preferentially blocks interleukin-1 beta binding.
    Clark BD; Ikejima T; Mancilla J; Orencole SF; Sirko SP; Ishii N; Okuda K; Dinarello CA
    J Interferon Cytokine Res; 1996 Dec; 16(12):1079-88. PubMed ID: 8974012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crystal structure of the type-I interleukin-1 receptor complexed with interleukin-1beta.
    Vigers GP; Anderson LJ; Caffes P; Brandhuber BJ
    Nature; 1997 Mar; 386(6621):190-4. PubMed ID: 9062193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new cytokine-receptor binding mode revealed by the crystal structure of the IL-1 receptor with an antagonist.
    Schreuder H; Tardif C; Trump-Kallmeyer S; Soffientini A; Sarubbi E; Akeson A; Bowlin T; Yanofsky S; Barrett RW
    Nature; 1997 Mar; 386(6621):194-200. PubMed ID: 9062194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.